Ubs Group Ag Viatris Inc Call Options Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 09, 2023	SELL	$9.59 - $11.35 $95,900 - $113,500	-10,000 Reduced 24.45%	30,900 $304,000
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $3.53 Million - $4.03 Million	-391,600 Reduced 90.54%	40,900 $408,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $5.93 Million - $7.9 Million	-644,400 Reduced 59.84%	432,500 $4.16 Million
Q4 2022 Feb 08, 2023	BUY	$8.72 - $11.56 $6.56 Million - $8.7 Million	752,200 Added 231.66%	1,076,900 $12 Million
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $16.1 Million - $21.1 Million	-1,898,800 Reduced 85.4%	324,700 $2.77 Million
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $18.4 Million - $22.7 Million	1,846,000 Added 489.01%	2,223,500 $23.3 Million
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $14.9 Million - $23.5 Million	-1,523,711 Reduced 80.14%	377,500 $4.11 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $15.7 Million - $19.1 Million	1,301,211 Added 216.87%	1,901,211 $25.7 Million
Q2 2021 Aug 13, 2021	BUY	$12.97 - $16.15 $7.78 Million - $9.69 Million	600,000 New	600,000 $8.57 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.